Toshihiro. Sakurai, et.al., Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide., The Journal of pharmacology and experimental therapeutics, 2016, 356

http://rdf.ncbi.nlm.nih.gov/pubmed/26574515

Toshihiro. Sakurai, et.al., Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide., The Journal of pharmacology and experimental therapeutics, 2016, 356

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Apoc2<em1Arem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5763016
• Apoc2<em2Arem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5763017

class

http://purl.org/net/cito/citesAsAuthority

• Apoc2<em1Arem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5763016
• Apoc2<em2Arem>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5763017

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal blood homeostasis_Apoc2<em1Arem>/Apoc2<em1Arem>
  http://metadb.riken.jp/0009642IC57BL6FVBNJApoc2em1AremApoc2em1AremApoc2em1Arem
• abnormal lipoprotein level_Apoc2<em1Arem>/Apoc2<em1Arem>
  http://metadb.riken.jp/0010329IC57BL6FVBNJApoc2em1AremApoc2em1AremApoc2em1Arem
• increased circulating triglyceride level_Apoc2<em1Arem>/Apoc2<+>
  http://metadb.riken.jp/0001552IC57BL6FVBNJApoc2em1AremApoc2Apoc2Apoc2em1Arem
• abnormal blood homeostasis_Apoc2<em2Arem>/Apoc2<em2Arem>
  http://metadb.riken.jp/0009642IC57BL6CBAApoc2em2AremApoc2em2AremApoc2em2Arem
• increased circulating triglyceride level_Apoc2<em2Arem>/Apoc2<em2Arem>
  http://metadb.riken.jp/0001552IC57BL6CBAApoc2em2AremApoc2em2AremApoc2em2Arem
• increased circulating VLDL triglyceride level_Apoc2<em2Arem>/Apoc2<+>
  http://metadb.riken.jp/0003975IC57BL6CBAApoc2em2AremApoc2Apoc2em2AremApoc2
• increased circulating VLDL triglyceride level_Apoc2<em2Arem>/Apoc2<em2Arem>
  http://metadb.riken.jp/0003975IC57BL6CBAApoc2em2AremApoc2em2AremApoc2em2Arem
• increased circulating triglyceride level_Apoc2<em2Arem>/Apoc2<+>
  http://metadb.riken.jp/0001552IC57BL6CBAApoc2em2AremApoc2Apoc2em2AremApoc2
• abnormal lipoprotein level_Apoc2<em2Arem>/Apoc2<em2Arem>
  http://metadb.riken.jp/0010329IC57BL6CBAApoc2em2AremApoc2em2AremApoc2em2Arem
• increased circulating VLDL triglyceride level_Apoc2<em1Arem>/Apoc2<+>
  http://metadb.riken.jp/0003975IC57BL6FVBNJApoc2em1AremApoc2Apoc2Apoc2em1Arem
• increased circulating HDL cholesterol level_Apoc2<em2Arem>/Apoc2<+>
  http://metadb.riken.jp/0001556IC57BL6CBAApoc2em2AremApoc2Apoc2em2AremApoc2
• decreased circulating HDL cholesterol level_Apoc2<em2Arem>/Apoc2<em2Arem>
  http://metadb.riken.jp/0000186IC57BL6CBAApoc2em2AremApoc2em2AremApoc2em2Arem
• decreased circulating HDL cholesterol level_Apoc2<em1Arem>/Apoc2<em1Arem>
  http://metadb.riken.jp/0000186IC57BL6FVBNJApoc2em1AremApoc2em1AremApoc2em1Arem
• increased circulating HDL cholesterol level_Apoc2<em1Arem>/Apoc2<+>
  http://metadb.riken.jp/0001556IC57BL6FVBNJApoc2em1AremApoc2Apoc2Apoc2em1Arem
• increased circulating VLDL triglyceride level_Apoc2<em1Arem>/Apoc2<em1Arem>
  http://metadb.riken.jp/0003975IC57BL6FVBNJApoc2em1AremApoc2em1AremApoc2em1Arem
• abnormal circulating cholesterol level_Apoc2<em1Arem>/Apoc2<em1Arem>
  http://metadb.riken.jp/0000180IC57BL6FVBNJApoc2em1AremApoc2em1AremApoc2em1Arem
• abnormal circulating cholesterol level_Apoc2<em2Arem>/Apoc2<em2Arem>
  http://metadb.riken.jp/0000180IC57BL6CBAApoc2em2AremApoc2em2AremApoc2em2Arem
• increased circulating triglyceride level_Apoc2<em1Arem>/Apoc2<em1Arem>
  http://metadb.riken.jp/0001552IC57BL6FVBNJApoc2em1AremApoc2em1AremApoc2em1Arem